Human Resources
Medtronic clinches 11th place on Best Workplaces list
People & Culture: Medtronic Australasia has been named one of the 2024 Best Workplaces in Australia by Great Place to Work, marking the medtech company’s third appearance on this prestigious list. Achieving a ranking of #11 underscores the Medtronic’s “dedication to building a strong, inclusive culture aligned with our Mission”.
The Best Workplaces list, announced at the Best Workplaces industry event hosted by Great Place To Work at W Hotel Sydney, announces 100 organisations in four different categories which represent over 144,500 employee voices across different industries in Australia.
The emerging trends in 2024 show that with a shift in the economic environment, workplace camaraderie has become less critical compared to the previous years, and the focus of what employees value has sharply turned towards stability and trust in leadership.
Liz Carnabuci, Vice President, Enterprise Accounts and Services, Japan and ANZ, VP Diabetes APAC & Greater China at Medtronic stated “This recognition as one of the Best Workplaces is a testament to our people-first approach. We are committed to creating an environment where every employee feels empowered, supported, and valued, and where diversity of thought and experience is not just encouraged but celebrated.”
“We’re so proud of the culture we have built at Medtronic. A culture that is underpinned by a number of initiatives and policies that play a crucial role in maintaining a safe space for transparent, open communication among our employees.”
Medtronic’s commitment to Inclusion, Diversity, and Equity (IDE) is central to its efforts to eliminate barriers to opportunity for all employees. The company leverages its Employee Resource Groups to create “a trusting environment where every voice is heard”.
This year, the “Empower Me” program has been particularly successful in nurturing emerging female talent, ensuring that they have the resources and support to thrive.
“Our flexible working policies, including the Yes Flex initiative and our ‘4 Weeks Work from Anywhere’ policy, highlights that we embrace flexibility as a part of our culture, supporting colleagues to achieve a healthy work-life balance,” Carnabuci added.
Medtronic has received its renewed citation from the Workplace Gender Equality Agency (WGEA) as an Employer of Choice for Gender Equality. Holding the citation for over 7 years showcases the company’s ongoing efforts to promote gender equality across all levels of our company.
Karen Newell, Senior Human Resources Director, Japan & ANZ, Diabetes APAC & Greater China, QA/RA APAC shared “Our company’s dedication to creating a truly inclusive environment is reflected in this achievement. Gender equality is fundamental to our success and to the well-being of our employees.
“We will continue to nurture our people and ensure they supported to grow and contribute equally.”
Among medtech companies, Boston Scientific is the only other company on the list, securing a ranking of #25.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
March PBAC agenda unveiled amid tensions over ‘unprecedented’ volume of submissions
The Department of Health has released the agenda for the March 2025 Pharmaceutical Benefits Advisory Committee (PBAC) meeting, unveiling plans […]
MoreNews & Trends - MedTech & Diagnostics
J&J MedTech exits DePuy Synthes spine portfolio
Johnson & Johnson MedTech will officially exit the DePuy Synthes Spine portfolio in Australia tomorrow, November 30, as part of […]
MoreNews & Trends - Pharmaceuticals
Home-grown hypertension polypill heads to regulatory approval
Australian-supported research has revealed remarkable Phase III clinical trial results for an innovative triple drug combination in the treatment of […]
MoreNews & Trends - Pharmaceuticals
Will Australia become first country to eliminate HIV transmission by 2030?
In the lead-up to World AIDS Day on December 1, the Albanese Government has unveiled the 9th National HIV Strategy, […]
More